Correlation Between Royal Helium and Helix BioPharma

Can any of the company-specific risk be diversified away by investing in both Royal Helium and Helix BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Royal Helium and Helix BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Royal Helium and Helix BioPharma Corp, you can compare the effects of market volatilities on Royal Helium and Helix BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Royal Helium with a short position of Helix BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Royal Helium and Helix BioPharma.

Diversification Opportunities for Royal Helium and Helix BioPharma

0.63

Correlation Coefficient

Royal Helium  Helix BioPharma

Poor diversification

The 3 months correlation between Royal and Helix is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Royal Helium and Helix BioPharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helix BioPharma Corp and Royal Helium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Royal Helium are associated (or correlated) with Helix BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helix BioPharma Corp has no effect on the direction of Royal Helium i.e., Royal Helium and Helix BioPharma go up and down completely randomly.

Pair Corralation between Royal Helium and Helix BioPharma

Assuming the 90 days horizon Royal Helium is expected to under-perform the Helix BioPharma. In addition to that, Royal Helium is 2.52 times more volatile than Helix BioPharma Corp. It trades about -0.05 of its total potential returns per unit of risk. Helix BioPharma Corp is currently generating about 0.23 per unit of volatility. If you would invest  77.00  in Helix BioPharma Corp on September 23, 2024 and sell it today you would earn a total of  20.00  from holding Helix BioPharma Corp or generate 25.97% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Royal Helium  vs.  Helix BioPharma Corp

Royal Helium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Royal Helium has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Helix BioPharma Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Helix BioPharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Helix BioPharma is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Royal Helium and Helix BioPharma

The main advantage of trading using opposite Royal Helium and Helix BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Royal Helium position performs unexpectedly, Helix BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helix BioPharma will offset losses from the drop in Helix BioPharma's long position.

The idea behind Royal Helium and Helix BioPharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.